SOCS1 and autoimmune disease: miR-155 potentiates the development of both regulatory T cells (Treg) and T helper 17 (Th17) cell subsets while augmenting IL-17A secretion through SOCS1 targeting, thereby influencing immune tolerance and autoimmune diseases [48].